Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Amgen
This Amgen tag page curates three articles, covering growth in biotech, dividend safety, and overlooked opportunities. Read how Amgen's fundamentals could shape your portfolio.
4 articles
Safe Amgen's Dividend? A Practical Investor's Guide
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Underrated Weight Loss Stocks: Two Buys for Long-Term Hold
The weight loss therapy wave has fireworks at the giants, but smart investors look for underrated weight loss stocks ...
Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...